Related Experiment Video
Updated: Jul 14, 2026

10:01
Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
Competitive Workflow: novel software architecture for automating drug design.
John Cartmell1, Damjan Krstajic, David E Leahy
1Cyprotex plc, 13-15 Beech Lane, Macclesfield SK10 4TG, UK.
Summary
Automating expert decision-making in drug discovery is crucial. Competitive Workflow, a multi-agent system, models expert knowledge to optimize data analysis and improve decision quality in laboratory processes.
Area of Science:
- Computational chemistry
- Artificial intelligence in drug discovery
- Bioinformatics
Background:
- Industrialization of laboratory processes in drug discovery generates vast data.
- Current decision-making relies on limited expert individuals, creating bottlenecks.
- Information management systems and computer-aided molecular design show promise but are limited by human decision-making.
Purpose of the Study:
- To introduce Competitive Workflow, a distributed multi-agent system for automating expert decision-making.
- To extend workflow architectures by modeling tacit expert knowledge for pathway selection.
- To review related workflow management systems and multi-agent approaches.
Main Methods:
- Development of a distributed multi-agent system (Competitive Workflow).
- Integration of workflow architectures with models of expert tacit knowledge.
- Application of the 'Discovery Bus' implementation to meta-quantitative structure-activity relationship analysis.
Main Results:
- Competitive Workflow automates decision-making, addressing a key bottleneck in drug discovery.
- The system models expert knowledge for selecting alternative pathways within workflows.
- Demonstrated application in meta-quantitative structure-activity relationship analysis.
Conclusions:
- Automating expert decision-making through systems like Competitive Workflow can significantly enhance drug discovery productivity.
- Distributed multi-agent systems offer a scalable solution for complex decision processes.
- The 'Discovery Bus' implementation shows practical utility in advanced cheminformatics tasks.
Related Concept Videos
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
